Impact BioMedical Inc.
IBO
$0.43
-$0.01-1.60%
AMEX
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 157.14% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 157.14% | -- | |||
| Cost of Revenue | -90.91% | -- | |||
| Gross Profit | 525.00% | -- | |||
| SG&A Expenses | -23.67% | 32.81% | |||
| Depreciation & Amortization | 0.00% | 1.77% | |||
| Other Operating Expenses | -0.91% | -4.35% | |||
| Total Operating Expenses | -16.72% | 14.85% | |||
| Operating Income | 17.78% | -14.16% | |||
| Income Before Tax | 89.72% | -1,023.00% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 89.72% | -1,023.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -16.67% | -45.45% | |||
| Net Income | 89.75% | -1,032.28% | |||
| EBIT | 17.78% | -14.16% | |||
| EBITDA | 92.01% | -14.07% | |||
| EPS Basic | 89.76% | -1,021.24% | |||
| Normalized Basic EPS | 89.78% | -1,026.49% | |||
| EPS Diluted | 89.78% | -972.73% | |||
| Normalized Diluted EPS | 89.78% | -1,026.49% | |||
| Average Basic Shares Outstanding | 0.00% | 1.02% | |||
| Average Diluted Shares Outstanding | 0.00% | 1.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||